taken aback [50:<0.1 mcg/L in 3 breastmilk samples from normal healthy mothers.[1] Infant Levels. Relevant published information was not found as of the revision date. Effects in Breastfed Infants Relevant published information was not found as of the revision date. Effects on Lactation and Breastmilk Relevant published information was not found as of the revision date. References 1. Brian SR, Bidlingmaier M, Wajnrajch MP et al. Treatment of acromegaly with pegvisomant during pregnancy: maternal and fetal effects. J Clin Endocrinol Metab. 2007;92:3374-7. PMID: 17595256 Pegvisomant Identification Substance Name Pegvisomant CAS Registry Number 218620-50-9 Drug Class Human Growth Hormone Analogues and Derivatives Growth Hormone Receptor Antagonists Administrative Information LactMed Record Number 607 Last Revision Date 20170411 Disclaimer Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site. Print this page Disclaimer: This information is not intended as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. Use of this website signifies your agreement to the Terms of Use and Online Privacy Policy. More about pegvisomant Side Effects During Pregnancy or Breastfeeding Dosage Information Drug Interactions Support Group En Español 1 Review Add your own review/rating Drug class: growth hormone receptor blockers Consumer resources Pegvisomant Pegvisomant Subcutaneous (Advanced Reading) Other brands: Somavert Professional resources Pegvisomant (AHFS Monograph) Pegvisomant (Wolters Kluwer) Related treatment guides Acromegaly> ] Drug Status Rx Availability Prescription only B Pregnancy Category No proven risk in humans N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Pegvisomant Rating 1 User Review 1 User Review Not Rated - Be the first! Drug Class Growth hormone receptor blockers travelers
discuss with Pegvisomant use while Breastfeeding appear
EmoticonEmoticon